Posts by: Janet Stewart, MSc

Janet Stewart, MSc

Janet Stewart is a life sciences writer and editor, who completed both PhD course work and oral examinations in the Department of Microbiology and Immunology at McGill University, and holds an M.Sc. in Virology and Immunology.

October 3, 2017October 3, 2017

Rituxan Seen to Benefit Mantle Cell Lymphoma Patients After Stem Cell Transplant

News

A Phase 3 trial of Rituxan (rituximab) as a maintenance therapy in adults with mantle cell lymphoma after a stem cell transplant found that the treatment improved survival rates over four years. ... Read more

September 29, 2017September 29, 2017

Gene Therapy-Based Cancer Treatment Delivers Promising Results in B-cell Malignancies, Study Shows

News

A gene therapy-based cancer treatment completely eliminated traces of tumor cells in 40 percent of patients with certain B-cell malignancies, according to data from a Phase 1/2a clinical trial. The study ... Read more

September 25, 2017

Radioactive Iodine Increases Risk of Thyroid Cancer Patient Developing Acute Myeloid Leukemia, Study Reports

News

Using radioactive iodine as a follow-up treatment to thyroid cancer surgery increases the risk of a patient developing acute myeloid leukemia and having a poorer outcome, a study reports. Researchers presented the ... Read more

August 11, 2017

FDA Advises Against Taking PharmaTech Liquids Due to Threat of Bacterial Contamination

News

The U.S. Food and Drug Administration is advising healthcare professionals and patients not to use liquid products manufactured by PharmaTech because they may be contaminated with a bacteria that can cause ... Read more

April 12, 2017

STRO-001 Kills Cancerous B-cells in Mice with Myeloma or Lymphoma, Study Shows

News

The antibody-based synthetic therapy STRO-001 killed cancerous B-cells in the blood of mice with multiple myeloma, and the animals remained tumor-free the entire four-month test period, according to a study. ... Read more

March 20, 2017March 20, 2017

Hodgkin Lymphoma Survivors with Family History of Cancer at High Risk of Second Cancer, Study Says

News

People successfully treated for Hodgkin’s lymphoma (HL) are more likely to develop a second cancer if they have a close relative with that type of cancer. The most common second ... Read more